Special Offer: Try the 'Picks Membership' for ONLY $37!
CLICK HERE TO LEARN MORE
RoboStreet – June 10, 2021
Bullish Biotech Breakout
Equity markets are in flux, sensing tighter Fed policy will emerge later this year to stem growing evidence of inflationary pressures. There are signs of upward pricing pressures in just about every industry and commodity around the world, the biggest surprise being the torrid rise in crude oil prices. As of Thursday, WTI crude was trading at $70/bbl even after the OPEC and non-OPEC nations agreed to increase supply.
Ironically, the bond market doesn’t seem to harbor the same level of nervousness, as the yield on the 10-year Treasury has slid to 1.48%, its lowest level since February. The debate over if and when the Fed will taper monthly bond and mortgage purchases has taken hold of the narrative, but thankfully, so has encouraging economic data that favors the long-term bull trend.
And remember we’re not talking about day-trading here. I’m looking for 50-100% gains inside of the next 3 months, so my weekly updates are timely enough for you to act.
The technical picture for the market is also a bit fuzzy, semi-directionless while it awaits news on inflation, more stimulus and tax policy. The $SPY continued to trade in the narrow range today. The short-term trading range remained between $410 and $425. The value stocks sold off (XLF, IYT, XHB). The influential technology stocks continue to chop in a tight range.
The $DXY has retested the recent lows. The $TLT continued to trade higher. The $SPY short-term support level is at $403-$410. The SPY overhead resistance is $423. Even if the $SPY is able to trade above the $423 level, the market can only make incremental highs until there is more clarity on key topics with big market moving potential.
I would consider rebalancing portfolio at this point to be more market neutral. I expect the second wave of the sell-off to restart as early as this week or next.
Based on our models, the $SPY can pull back 10-15% from the all-time highs in the next 2-6 weeks. Based on our models, the market (SPY) will trade in the range between $388 and $425 for the next 2-4 weeks.
Be it up, down or sideways markets, there are always opportunities to make money, but it requires having a system in place that can discern what the market cares about and what it doesn’t. This is true of the big picture issues as wall as individual stock and ETF selection.
Our RoboInvestor advisory service is driven by artificial intelligence that not only screens for great stock and ETF recommendations, the platform also takes into account historical data that impacts the direction all the various assets traded. Our AI model unveils the highest risk/reward trades in blue-chip stocks and ETFs that represent all the various sub-sectors of the equity markets, indexes, commodities, precious metals, currencies, interest rates, bearish hedges and volatility.
Our AI system is always thinking, always learning, and always crunching data 24/7 to ferret out the best profit-generating opportunities. One of them that is starting to show up within our indicators is the biotech sector, specifically the SPDR S&P Biotech ETF (XBI) that represents the best proxy for the sector.
The ETF has widely diversified with the top 10 holdings make up less than 10% of total assets where there are 192 holdings of which 100% are U.S.-based companies.
What is interesting about the chart pattern of XBI is the sudden emergence of the shares up and through its 20, 50, and 200-day moving averages on a big spike in volume that is triggering our interest in this trade.
Our AI platform gives XBI a Model Grade “C” rating, which is neutral, but gaining favor as more signals are turning bullish. Shares of XBI trade at around $135 and the latest Predicted Resistance price target is up at $162.36, or about 20% above where the stock currently trades.
Depending on further confirmation from our AI tools, we might well be recommending XBI to our RoboInvestor members in the coming days, which might behoove readers of this column to join up and get in on this and other compelling trades. We publish a bi-monthly newsletter that is delivered over the weekend with two new recommendations to act on when the market opens Monday. We harvest profits when our AI signals determine when to do so and maintain a constant portfolio of roughly 15-25 positions at any given time depending on market conditions.
Our AI-driven system has generated a highly successful stream of profits for over three years, posting an amazing 91.3% Winnings Trades Percentage.
Make a smart decision today and become a RoboInvestor where you put the power of AI to work for your portfolio at a time when new elements of uncertainty are permeating the market landscape. Filtering out the noise and confusion to identify the best trades is what we do for our members at RoboInvestor, and I’ll be first to welcome you aboard as we build wealth together. Join today and up your winning streak starting tomorrow!
And remember we’re not talking about day-trading here. I’m looking for 50-100% gains inside of the next 3 months, so my weekly updates are timely enough for you to act.
*Please note: RoboStreet is part of your free subscription service. It is not included in any paid Tradespoon subscription service. Vlad Karpel only trades his own personal money in paid subscription services. If you are a paid subscriber, please review your Premium Member Picks, ActiveTrader, MonthlyTrader, or RoboInvestor recommendations. If you are interested in receiving Vlad’s personal picks, please click here.
Please share this Tradespoon Market Commentary with your friends.
Comments Off on
Tradespoon Tools make finding winning trades in minute as easy as 1-2-3.
Our simple 3 step approach has resulted in an average return of almost 20% per trade!
